Back to all papers

Hypothalamic volume and cell-type changes in ageing and Alzheimer's disease.

November 18, 2026pubmed logopapers

Authors

Yu D,Germann J,Murtaza G,Hajdarovic KH,Babcock KR,Dehkordi SK,Jackson AC,Delalle I,Orr ME,Zare H,Singh R,MacCoss MJ,Noble WS,Vlassenko AG,Goyal MS,Webb AE

Affiliations (29)

  • Molecular Biology, Cell Biology, and Biochemistry Graduate Program, Brown University, Providence, RI, USA.
  • The Buck Institute for Research on Aging, Novato, CA, USA.
  • Department of Genome Sciences, University of Washington, Seattle, WA, USA.
  • Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
  • Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, Ontario, Canada.
  • Department of Computer Science, Brown University, Providence, RI, USA.
  • Neuroscience Graduate Program, Brown University, Providence, RI, USA.
  • Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, San Antonio, TX, USA.
  • Department of Cell Systems and Anatomy, University of Texas Health San Antonio, San Antonio, TX, USA.
  • Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
  • Department of Physiology and Neurobiology, University of Connecticut, Storrs, CT, USA.
  • The Connecticut Institute for the Brain and Cognitive Sciences (IBACS), Storrs, CT, USA.
  • Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.
  • St. Louis VA Medical Center, St. Louis, MO, USA.
  • Haba Businesses, San Antonio, TX, USA.
  • The Oncinfo Laboratory, San Antonio, TX, USA.
  • Center for Computational Molecular Biology, Brown University, Providence, RI, USA.
  • Siebel School of Computing and Data Science, University of Illinois Urbana-Champaign, Urbana, IL, USA.
  • Paul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, WA, USA.
  • Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
  • Neuroimaging Laboratories Research Center, Washington University School of Medicine, St. Louis, MO, USA.
  • Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.
  • Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA. [email protected].
  • Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA. [email protected].
  • Neuroimaging Laboratories Research Center, Washington University School of Medicine, St. Louis, MO, USA. [email protected].
  • Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA. [email protected].
  • Department of Neuroscience, Washington University School of Medicine, St. Louis, MO, USA. [email protected].
  • The Buck Institute for Research on Aging, Novato, CA, USA. [email protected].

Abstract

Alterations in metabolism, stress response, sleep, circadian rhythms and neuroendocrine processes are key features of ageing and neurodegeneration<sup>1,2</sup>. These fundamental processes are regulated by the hypothalamus, yet how its functionally distinct subregions and cell types change during human ageing and Alzheimer's disease (AD) remains largely unexplored. Here we present HypoAD, an atlas of the human hypothalamus in ageing and AD, including high-resolution magnetic resonance imaging from 458 individuals and single-nucleus RNA sequencing of 614,403 nuclei from young participants, patients with AD and age-matched non-dementia control participants. We show that hypothalamic subregions governing metabolism, stress and circadian rhythms are particularly vulnerable, showing notable changes in both volumes and gene expression during ageing and AD. At the molecular level, machine learning models identified the inflammatory response and regulators of circadian rhythms as key cellular predictors of AD. These signatures were reflected in specific cell types: microglia transitioned to a pro-inflammatory state, whereas inhibitory neurons within sleep-regulating and circadian-regulating hypothalamic subregions showed the most profound transcriptional alterations, including disruptions in ligand-receptor interactions and G-protein-coupled receptor signalling. HypoAD provides a high-resolution volumetric map and a transcriptomic atlas of the human hypothalamus in ageing and AD, relating lifestyle and behavioural changes to the relevant volumetric and molecular pathways. In addition, HypoAD provides a framework to investigate hypothalamic dysfunction and establishes a roadmap for targeted interventions aimed at mitigating physiological disruptions to potentially slow disease progression.

Topics

Journal Article

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.